PDEA ‘thumbs up’ on legalizing medical marijuana; DDB defers to health experts’ position | Inquirer News

PDEA ‘thumbs up’ on legalizing medical marijuana; DDB defers to health experts’ position

/ 04:17 PM September 28, 2022


MANILA, Philippines — The Philippine Drug Enforcement Agency (PDEA) has given a “thumbs up” to the legalization of medical marijuana in the country, but the Dangerous Drug Board (DDB) said its position would be determined by its counterparts in the health sector


PDEA director general Wilkins Villanueva and DDB Secretary Catalino Cuy presented their stance on this issue when asked by Senator Robin Padilla during the finance subcommittee deliberations on the proposed 2023 budget of both agencies on Wednesday.

Even though Villanueva quickly approved of legalizing medical marijuana usage, Cuy said the DBB’s position on the issue would be determined by its health expert members.


“Remember, ang DBB ay board. Meron po kaming members diyan katulad ng Department of Health (DOH) na sila po ang mga eksperto sa bagay na iyan. Mga medical matter. Kaya we defer sa position and recommendation ng DOH [at] ng Philippine Medical Association,” Cuy explained.

(Remember, DBB is a board. We have members from the DOH, who are experts in these medical matters, so we defer to the position and recommendation of the DOH and the Philippine Medical Association.)

He assured them that the DBB would back any research into medical marijuana’s potential benefits and noted that the drug is already legal in the country for “compassionate use.”

Under the Comprehensive Dangerous Drugs Act of 2022, marijuana is classified as a dangerous drug, but terminally ill patients may apply for a special permit from the Food and Drug Administration for compassionate purposes.

The neophyte lawmaker noted, however, that only the rich and those with connections could enjoy such a privilege.

“Hindi nakikinibang ang mahihirap na tao dito. Nakakalungkot po ito kasi ang presyo po nito, kapag dumaan sa inyong butihing opisina at binigyan niyo po ng permit. Bibilhin sa abroad. Nagkakahalaga po ito ng $30,000 per year. Hindi po ito kayang bilhin ng mga mahihirap na tao,” he said.

(Poor people cannot benefit from this. It’s sad because the cost of this once it goes through your good office, then is granted a permit, and later bought abroad amounts to $30,000 per year. Poor people will not be able to afford this.)


Padilla stressed that the poor should not be denied the benefits of medical marijuana.

“Ito naman po ay medical. Hindi po ito patungkol sa recreation. Hindi po natin ine-encourage iyan,” he added.
(This is medical, not recreational. We don’t encourage the latter.)

Padilla then restated a part of his earlier filed Senate Bill No. 230 or the “Medical Cannabis Compassionate Access Act of the Philippines,” which aims to legalize the selling of medical marijuana only in capsules or oil and never without a prescription from a doctor.

Once legal, the government will also designate a place where marijuana can be planted and regulated by authorized farmers.

Senator Bong Go, meanwhile, said a more in-depth discussion on the matter will soon be done before the upper chamber’s committee on health, which he leads.


Padilla assures public medical marijuana bill has enough safeguards vs abuse

Senate panel approves PDEA, DDB 2023 budgets

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Dangerous Drug Board, legalize medical marijuana, PDEA
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.